potassium phosphate, monobasic potassium phosphate, dibasic injection,

FDA Drug Profile — POTASSIUM PHOSPHATES

potassium phosphate, monobasic potassium phosphate, dibasic injection, is listed in the FDA National Drug Code directory with 7 NDC codes, marketed under brand name including POTASSIUM PHOSPHATES. Available dosage form: solution, concentrate.

Drug details

Generic Name
potassium phosphate, monobasic potassium phosphate, dibasic injection,
Brand Names
POTASSIUM PHOSPHATES
Application Number
ANDA216344
Sponsor
Amneal Pharmaceuticals Private Limited
NDC Codes
7
Dosage Forms
SOLUTION, CONCENTRATE
Routes
INTRAVENOUS
Active Ingredients
POTASSIUM PHOSPHATE, MONOBASIC, POTASSIUM PHOSPHATE, DIBASIC

Indications and Usage

1 INDICATIONS AND USAGE Potassium phosphates injection is indicated as a source of phosphorus: in intravenous fluids to correct hypophosphatemia in adults and pediatric patients when oral or enteral replacement is not possible, insufficient or contraindicated. for parenteral nutrition in adults and pediatric patients when oral or enteral nutrition is not possible, insufficient or contraindicated. Potassium phosphates injection is a phosphorus replacement product indicated as a source of phosphorus: in intravenous fluids to correct hypophosphatemia in adults and pediatric patients when oral or enteral replacement is not possible, insufficient or contraindicated. ( 1 ) for parenteral nutrition in adults and pediatric patients when oral or enteral nutrition is not possible, insufficient or contraindicated. ( 1 )

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.